Susquehanna International Group, LLP Codex Dna, Inc. Call Options Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	N/A	-14,800 Reduced 51.93%	13,700 $25,000
Q3 2023 Nov 14, 2023	SELL	N/A	-14,000 Reduced 32.94%	28,500 $52,000
Q2 2023 Aug 11, 2023	BUY	N/A	21,300 Added 100.47%	42,500 $78,000
Q1 2023 May 16, 2023	BUY	$1.3 - $2.15 $27,560 - $45,580	21,200 New	21,200 $39,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.